CN109096251B - 具有组胺受体双重拮抗活性的化合物及用途 - Google Patents
具有组胺受体双重拮抗活性的化合物及用途 Download PDFInfo
- Publication number
- CN109096251B CN109096251B CN201811122106.3A CN201811122106A CN109096251B CN 109096251 B CN109096251 B CN 109096251B CN 201811122106 A CN201811122106 A CN 201811122106A CN 109096251 B CN109096251 B CN 109096251B
- Authority
- CN
- China
- Prior art keywords
- compound
- histamine
- inflammatory
- cyclohepta
- ylidene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811122106.3A CN109096251B (zh) | 2018-09-26 | 2018-09-26 | 具有组胺受体双重拮抗活性的化合物及用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811122106.3A CN109096251B (zh) | 2018-09-26 | 2018-09-26 | 具有组胺受体双重拮抗活性的化合物及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109096251A CN109096251A (zh) | 2018-12-28 |
CN109096251B true CN109096251B (zh) | 2020-11-03 |
Family
ID=64867756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811122106.3A Active CN109096251B (zh) | 2018-09-26 | 2018-09-26 | 具有组胺受体双重拮抗活性的化合物及用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109096251B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113880801A (zh) | 2020-07-03 | 2022-01-04 | 合肥医工医药股份有限公司 | 一类三环化合物、其制备方法及其医药用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2042421B1 (es) * | 1992-05-22 | 1994-08-01 | Uriach & Cia Sa J | Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina. |
CN102260253B (zh) * | 2011-06-09 | 2015-02-18 | 中国药科大学 | 苯并[5,6]环庚基[1,2-b]吡啶衍生物、制备方法、药物组合物及其抗过敏性疾病的用途 |
CN107602534B (zh) * | 2017-09-05 | 2020-04-24 | 合肥医工医药股份有限公司 | 具有抗组胺和抗炎活性的化合物及其制备方法和应用 |
-
2018
- 2018-09-26 CN CN201811122106.3A patent/CN109096251B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN109096251A (zh) | 2018-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7367169B2 (ja) | Rip1阻害剤化合物並びにそれを製造及び使用するための方法 | |
AU2020343681B2 (en) | Heterocyclic RIP1 kinase inhibitors | |
CN105073738B (zh) | 作为钠通道调节剂的喹啉及喹喔啉酰胺类 | |
TWI316937B (en) | Spirocyclic thrombin receptor antagonists | |
CN104968647B (zh) | 作为钠通道调节剂的酰胺 | |
CN108699078A (zh) | 噻吩并嘧啶二酮acc抑制剂的固体形式及其制备方法 | |
JP2021519282A (ja) | HIF−2−αの阻害薬による消化器系の炎症軽減方法 | |
CN108395452A (zh) | 作为钠通道调节剂的吡啶酮酰胺的前药 | |
JP2003534377A (ja) | メラノコルチン受容体作働薬 | |
JP2018514524A (ja) | 5−芳香族アルキニル基置換ベンズアミド系化合物並びにその製造方法、薬物組成物及び使用 | |
JP2021526123A (ja) | オートタキシン阻害剤とその使用 | |
JP2001504857A (ja) | 3−ピリジルエナンチオマーおよび鎮痛薬としてのその使用 | |
CN102712589A (zh) | 作为醛固酮合酶抑制剂的芳基-吡啶衍生物 | |
TW200938540A (en) | Amide compounds as boosters of antivirals | |
WO2016084866A1 (ja) | 新規ジアザビシクロ誘導体 | |
WO2016088813A1 (ja) | 新規ジアザビシクロ[2.2.2]オクタン誘導体 | |
US20230381148A1 (en) | Hdac6 inhibitors for treatment of metabolic disease and hfpef | |
CN110545814A (zh) | 趋化因子cxcr4受体调节剂及其相关用途 | |
CN109096251B (zh) | 具有组胺受体双重拮抗活性的化合物及用途 | |
CN107207476A (zh) | 吲哚和氮杂吲哚衍生物及其用于神经退化性疾病中的用途 | |
TW201726671A (zh) | N-[2-(3-胺基-2,5-二甲基-1,1-二氧化-5,6-二氫-2h-1,2,4-硫二氮-5-基)-1,3-噻唑-4-基]醯胺 | |
JP2021529159A (ja) | N−置換テトラヒドロチエノピリジン誘導体及びその使用 | |
CN109734712A (zh) | 芳基或杂芳基取代的吡咯烷酰胺衍生物及其用途 | |
WO2015114660A1 (en) | Novel heterobicyclic compounds as kappa opioid agonists | |
US10377763B2 (en) | Morphinan derivative and medical usage thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 230088 No. 669 Changjiang West Road, hi tech Zone, Anhui, Hefei Applicant after: HEFEI INDUSTRIAL PHARMACEUTICAL INSTITUTE Co.,Ltd. Applicant after: HEFEI AMVITE PHARMACEUTICAL Co.,Ltd. Address before: 230088 No. 669 Changjiang West Road, hi tech Zone, Anhui, Hefei Applicant before: HEFEI YIGONG MEDICINE Co.,Ltd. Applicant before: HEFEI AMVITE PHARMACEUTICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Compounds with double antagonistic activity of histamine receptor and their applications Effective date of registration: 20221214 Granted publication date: 20201103 Pledgee: Jiujiang Bank Co.,Ltd. Anhui Pilot Free Trade Zone Hefei Area Sub branch Pledgor: HEFEI INDUSTRIAL PHARMACEUTICAL INSTITUTE Co.,Ltd.|HEFEI AMVITE PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980027289 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |